Dindindino
2021-12-16
Good!
18 Stocks Moving in Thursday's Pre-Market Session
免责声明：上述内容仅代表发帖人个人观点，不构成本平台的任何投资建议。
分享至
微信
复制链接
精彩评论
我们需要你的真知灼见来填补这片空白
打开APP，发表看法
APP内打开
发表看法
4
{"i18n":{"language":"zh_CN"},"detailType":1,"isChannel":false,"data":{"magic":2,"id":690840935,"tweetId":"690840935","gmtCreate":1639657892580,"gmtModify":1639657892831,"author":{"id":3585008979244156,"idStr":"3585008979244156","authorId":3585008979244156,"authorIdStr":"3585008979244156","name":"Dindindino","avatar":"https://static.tigerbbs.com/8aa54f4d7f1ed33d80d2d8d18918fb30","vip":1,"userType":1,"introduction":"","boolIsFan":false,"boolIsHead":false,"crmLevel":2,"crmLevelSwitch":0,"individualDisplayBadges":[],"fanSize":19,"starInvestorFlag":false},"themes":[],"images":[],"coverImages":[],"extraTitle":"","html":"<html><head></head><body><p>Good! </p></body></html>","htmlText":"<html><head></head><body><p>Good! </p></body></html>","text":"Good!","highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":0,"repostSize":0,"favoriteSize":0,"link":"https://laohu8.com/post/690840935","repostId":1128981049,"repostType":4,"repost":{"id":"1128981049","kind":"news","pubTimestamp":1639657469,"share":"https://www.laohu8.com/m/news/1128981049?lang=&edition=full","pubTime":"2021-12-16 20:24","market":"us","language":"en","title":"18 Stocks Moving in Thursday's Pre-Market Session","url":"https://stock-news.laohu8.com/highlight/detail?id=1128981049","media":"Benzinga","summary":"Gainers\n\nCalliditas Therapeutics AB rose 36.5% to $25.45 in pre-market trading after the company ann","content":"<p><b>Gainers</b></p>\n<ul>\n <li><b>Calliditas Therapeutics AB</b> rose 36.5% to $25.45 in pre-market trading after the company announced it was granted by the FDA accelerated approval of TARPEYO to reduce proteinuria in lgA nephropathy.</li>\n <li><b>CooTek (Cayman) Inc.</b> rose 15.6% to $0.5589 in pre-market trading after dropping more than 10% on Wednesday.</li>\n <li><b>Petros Pharmaceuticals, Inc.</b> rose 13.5% to $3.26 in pre-market trading after gaining over 4% on Wednesday.</li>\n <li><b>American Virtual Cloud Technologies, Inc.</b> rose 13.5% to $1.74 in pre-market trading after the company’s Kandy Communications business unit said that full Public Switched Telephone Network (PSTN) replacement services are now available in Brazil and China.</li>\n <li><b>Retail Value Inc.</b> rose 12.2% to $6.80 in pre-market trading after the company reported the sale of Willowbrook Plaza. The company reported a special common share distribution and preferred stock repurchase.</li>\n <li><b>Tyme Technologies, Inc.</b> rose 10.3% to $0.8165 in pre-market trading. TYME Technologies recently said TYME-19 'demonstrated an antiviral effect against SARS CoV-2 in human lung epithelial cells.'</li>\n <li><b>Assertio Holdings, Inc.</b> rose 9.6% to $1.48 in pre-market trading after the company reported the acquisition of Otrexup® (methotrexate) a drug device combination from Antares Pharma, Inc.</li>\n <li><b>Enveric Biosciences, Inc.</b> rose 7.5% to $1.14 in pre-market trading after declining over 6% on Wednesday.</li>\n <li><b>Co-Diagnostics, Inc.</b> rose 7.2% to $8.92 in pre-market trading. Co-Diagnostics reported a partnership with TiiCKER to 'increase its connection to retail investors.'</li>\n <li><b>Canoo Inc.</b> rose 6.9% to $9.24 in pre-market trading after the company boosted production guidance and targets for US facilities.</li>\n <li><b>HUTCHMED (China) Limited</b> rose 6.9% to $34.09 in pre-market trading.</li>\n <li><b>Legend Biotech Corporation</b> rose 6.7% to $43.90 in pre-market trading. Legend Biotech recently reported an offering of $300 million in ADSs.</li>\n <li><b>Navidea Biopharmaceuticals, Inc.</b> rose 6% to $1.23 in pre-market trading. Navidea Biopharmaceuticals terminated purchase agreement of $25 million worth of stock. The company also completed full enrollment in Phase 2b normative database study to support its rheumatoid arthritis program.</li>\n</ul>\n<p><b>Losers</b></p>\n<ul>\n <li><b>IronNet, Inc.</b> fell 19.3% to $5.49 in pre-market trading after the company reported Q3 sales results were lower year over year.</li>\n <li><b>Zhangmen Education Inc.</b> fell 8.2% to $1.12 in pre-market trading.</li>\n <li><b>Lennar Corporation</b> shares fell 7.2% to $105.00 in pre-market trading after the company reported downbeat earnings for its fourth quarter. The company said it sees Q1 new orders of 14,800 to 15,100.</li>\n <li><b>Danimer Scientific, Inc.</b> shares fell 6.5% to $9.90 in pre-market trading after the company reported a proposed convertible senior notes offering.</li>\n <li><b>Inpixon</b> fell 6.2% to $0.67 in pre-market trading after gaining around 7% on Wednesday.</li>\n</ul>","source":"lsy1606299360108","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>18 Stocks Moving in Thursday's Pre-Market Session</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n18 Stocks Moving in Thursday's Pre-Market Session\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-12-16 20:24 GMT+8 <a href=https://www.benzinga.com/news/21/12/24640676/18-stocks-moving-in-thursdays-pre-market-session><strong>Benzinga</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Gainers\n\nCalliditas Therapeutics AB rose 36.5% to $25.45 in pre-market trading after the company announced it was granted by the FDA accelerated approval of TARPEYO to reduce proteinuria in lgA ...</p>\n\n<a href=\"https://www.benzinga.com/news/21/12/24640676/18-stocks-moving-in-thursdays-pre-market-session\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"GOEV":"Canoo Inc.","PTPI":"Petros Pharmaceuticals Inc"},"source_url":"https://www.benzinga.com/news/21/12/24640676/18-stocks-moving-in-thursdays-pre-market-session","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1128981049","content_text":"Gainers\n\nCalliditas Therapeutics AB rose 36.5% to $25.45 in pre-market trading after the company announced it was granted by the FDA accelerated approval of TARPEYO to reduce proteinuria in lgA nephropathy.\nCooTek (Cayman) Inc. rose 15.6% to $0.5589 in pre-market trading after dropping more than 10% on Wednesday.\nPetros Pharmaceuticals, Inc. rose 13.5% to $3.26 in pre-market trading after gaining over 4% on Wednesday.\nAmerican Virtual Cloud Technologies, Inc. rose 13.5% to $1.74 in pre-market trading after the company’s Kandy Communications business unit said that full Public Switched Telephone Network (PSTN) replacement services are now available in Brazil and China.\nRetail Value Inc. rose 12.2% to $6.80 in pre-market trading after the company reported the sale of Willowbrook Plaza. The company reported a special common share distribution and preferred stock repurchase.\nTyme Technologies, Inc. rose 10.3% to $0.8165 in pre-market trading. TYME Technologies recently said TYME-19 'demonstrated an antiviral effect against SARS CoV-2 in human lung epithelial cells.'\nAssertio Holdings, Inc. rose 9.6% to $1.48 in pre-market trading after the company reported the acquisition of Otrexup® (methotrexate) a drug device combination from Antares Pharma, Inc.\nEnveric Biosciences, Inc. rose 7.5% to $1.14 in pre-market trading after declining over 6% on Wednesday.\nCo-Diagnostics, Inc. rose 7.2% to $8.92 in pre-market trading. Co-Diagnostics reported a partnership with TiiCKER to 'increase its connection to retail investors.'\nCanoo Inc. rose 6.9% to $9.24 in pre-market trading after the company boosted production guidance and targets for US facilities.\nHUTCHMED (China) Limited rose 6.9% to $34.09 in pre-market trading.\nLegend Biotech Corporation rose 6.7% to $43.90 in pre-market trading. Legend Biotech recently reported an offering of $300 million in ADSs.\nNavidea Biopharmaceuticals, Inc. rose 6% to $1.23 in pre-market trading. Navidea Biopharmaceuticals terminated purchase agreement of $25 million worth of stock. The company also completed full enrollment in Phase 2b normative database study to support its rheumatoid arthritis program.\n\nLosers\n\nIronNet, Inc. fell 19.3% to $5.49 in pre-market trading after the company reported Q3 sales results were lower year over year.\nZhangmen Education Inc. fell 8.2% to $1.12 in pre-market trading.\nLennar Corporation shares fell 7.2% to $105.00 in pre-market trading after the company reported downbeat earnings for its fourth quarter. The company said it sees Q1 new orders of 14,800 to 15,100.\nDanimer Scientific, Inc. shares fell 6.5% to $9.90 in pre-market trading after the company reported a proposed convertible senior notes offering.\nInpixon fell 6.2% to $0.67 in pre-market trading after gaining around 7% on Wednesday.","news_type":1},"isVote":1,"tweetType":1,"viewCount":942,"commentLimit":10,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"symbols":[],"verified":2,"subType":0,"readableState":1,"langContent":"CN","currentLanguage":"CN","warmUpFlag":false,"orderFlag":false,"shareable":true,"causeOfNotShareable":"","featuresForAnalytics":[],"commentAndTweetFlag":false,"andRepostAutoSelectedFlag":false,"upFlag":false,"length":5,"xxTargetLangEnum":"ZH_CN"},"commentList":[],"isCommentEnd":true,"isTiger":false,"isWeiXinMini":false,"url":"/m/post/690840935"}
精彩评论